[1]
P. Zimmet, G. Alberti. The metabolic syndrome: progress towards one definition for an epidemic of our time, J. Nat. Clin. Pract. Endocrinol. Metab. 4 (2008) 239.
DOI: 10.1038/ncpendmet0834
Google Scholar
[2]
I.E. Chazova, V. B Mychka, V.V. Gornostaev, I.M. Dvoskina, V.B. Sergienko, The state of cerebral perfusion in patients with metabolic syndrome, Insul't (J. Insult) (in Russian). 3 (2005) 8-13.
DOI: 10.1097/00004872-200406002-00376
Google Scholar
[3]
The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives, Am. J. Epidemiol. 129 (1989) 687-702.
DOI: 10.1093/oxfordjournals.aje.a115184
Google Scholar
[4]
O.D. Ostroumova, I.V. Desnitskaya, Approaches to the treatment of arterial hypertension in hospital: the correction of arterial tension and the state of cognitive functions, J. Сonsilium Medicum (in Russian). 2 (2005) 14-17.
Google Scholar
[5]
Z.A. Suslina, L.A. Geraskina, A.V. Fonyakin, Arterial hypertension, brain vascular pathology and antihypertensive treatment, Moscow (in Russian), (2006).
Google Scholar
[6]
RSC National Guidelines for diagnosis and treatment of metabolic syndrome, Cardiovascular therapy and prevention (in Russian). 6 (2007), App. 2, 45-50. 1560-4071.
Google Scholar
[7]
Y. Yonekura, S. Nishizawa, T. Mukai, SPECT with 99m-Tc- d, l –hexamethyl propylene amine oxime (HM-PAO) compared with regional cerebral blood flow measured by PET. Effects of linearization, J. Cerebral Blood Flow & Metab. 8 (1988) 82-89.
DOI: 10.1038/jcbfm.1988.36
Google Scholar
[8]
N.A. Lassen, A.R. Andersen, L. Fribrg, O.B. Paulson, The Retention of [99m-Tc]-d, l, -HMPAO in the Human Brain after Intracarotid Bolus injection: A Kinetic Analysis, J. Cerebral Blood Flow & Metab. 8 (1988) 13-22.
DOI: 10.1038/jcbfm.1988.28
Google Scholar
[9]
A.R. Luriya, The higher cortical functions of a human being and their disorders in local brain injuries, Moscow State University Publ., Moscow, (1969).
Google Scholar
[10]
D. Wechsler, Wechsler Memory Scale-Revised. Manual. Psychological Corporation, New York, (1987).
Google Scholar
[11]
K.M. Mamyrbaeva, V.B. Mychka, V.B. Sergienko, I. E Chazova, Metabolic syndrome and angiotensin II receptor antagonists, J. Cardiovascular therapy and prevention (in Russian). 2 (2007) 42-51.
Google Scholar
[12]
K. Shimada, A Kawamoto, K. Matsubayashi, T. Ozawa, Silent cerebrovascular disease in the elderly. Correlation with ambulatory pressure, J. Hypertension. 6 (1990) 692-699.
DOI: 10.1161/01.hyp.16.6.692
Google Scholar
[13]
M. Clozel, H. Kuhn, F. Hefti, Effects of angiotensin-converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats, J. Hypertension. 16 (1990) 532-540.
DOI: 10.1161/01.hyp.16.5.532
Google Scholar
[14]
G.Y. Lip, C.R. Gibbs, D. Beevers, Blood pressure monitoring and stroke: more questions than answers, J. Stroke 29 (1998) 1495-1497.
DOI: 10.1161/01.str.29.8.1495
Google Scholar
[15]
I.E. Chazova, V.B. Mychka, K.M. Mamyrbaeva, V.V. Gornostaev, I.M. Dvoskina, V.B. Sergienko, Cerebrovascular complications in metabolic syndrome: possible approaches to decrease risk, J. Therapeutic archive (in Russian). 6 (2004) 74-80.
Google Scholar
[16]
S.V. Orlov, M.A. Domashenko, M.V. Kostyreva, A.A. Shabalina, V.G. Ionova, M.M. Tanashyan, Hemorheology and hemostasis in patients with ischemic stroke associated with metabolic syndrome, J. Clinical Medicine (in Russian). 1 (2007) 40-43.
Google Scholar
[17]
I. Juhan-Vague, S. G Thompson, J. Jespercen, Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris, J. Arterioscl. Thromb. 13 (1993) 1865-1873.
DOI: 10.1161/01.atv.13.12.1865
Google Scholar
[18]
L. Lind, S. Grantsam, J. Millgard, Endothelium-dependent vasodilatation in hypertension - A review, J. Blood Pressure 9 (2000) 4-15.
Google Scholar
[19]
F. Nobili, G. Rodriguez, S. Marenco, F. De Carli, M. Gambaro, C. Castello, R. Pontremoli, G. Rosadini, Regional cerebral blood flow in chronic hypertension. A correlative study, Stroke. 8 (1993) 1148–1153.
DOI: 10.1161/01.str.24.8.1148
Google Scholar
[20]
R.M. Evans, C.L. Emsley, S. Gao, A. Sahota, K.S. Hall, M.R. Farlow, H. Hendrie, Serum cholesterol, APOE genotype, and the risk of Alzheimer's disease: a population-based study of African, J. Americans. Neurology. 54 (2000) 240-242.
DOI: 10.1212/wnl.54.1.240
Google Scholar
[21]
A. Kanaya, E. Barrett-Connor, G. Gildengorin, K. Yaffe, Change in cognitive function by glucose tolerance status among older adults: a 4-year prospective study of the Rancho Bernardo study cohort, J. Arch. Intern. Med. 164 (2004) 1327-1333.
DOI: 10.1001/archinte.164.12.1327
Google Scholar
[22]
G.F. Watts, D.A. Playford, Dyslipoproteinaemia and hyperoxidative stress in patogenesis of endotelial dysfunction in non-insulin-dependent diabetes mellitus: anhypotesis, J. Atherosclerosis. 28 (1998)166-172.
DOI: 10.1016/s0021-9150(98)00170-1
Google Scholar
[23]
N. Yu. Efimova, V.I. Chernov, I. Yu Efimova, Sh.D. Ahmedov, Yu.B. Lishmanov, The state of cerebral hemodynamics and cognitive function in patients with IHD after coronary artery bypass surgery, J. Angiology and Vascular Surgery (in Russian). 3 (2004).
DOI: 10.1016/j.ejcts.2005.10.001
Google Scholar
[24]
N. Yu. Efimova, I. Yu Efimova, V.I. Chernov, Sh.D. Ahmedov, Yu. Yu. Vechersky, Yu.K. Podoksenov, Yu.B. Lishmanov, Cognitive functions and perfusion of the brain in patients with IHD after coronary artery bypass surgery, J. Thoracic and Cardiovascular Surgery (in Russian), 6 (2002).
DOI: 10.1016/j.ejcts.2005.10.001
Google Scholar